These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 18299678

  • 1. Serum prolidase activity in postmenopausal osteoporosis.
    Namiduru ES, Binnur Erbagci A, Celik A, Yilmaz M, Tarakçioglu M.
    Minerva Med; 2007 Dec; 98(6):647-51. PubMed ID: 18299678
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK, Chadha M, Modi KD, Kumar KM, Mehrotra R, Sriram U.
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [Abstract] [Full Text] [Related]

  • 6. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ, Damilakis J, Velegrakis GA, Skouteris CA, Fragouli I, Goumenou A, Matalliotakis J, Koumantakis EE.
    Maturitas; 2008 Mar 20; 59(3):226-33. PubMed ID: 18342460
    [Abstract] [Full Text] [Related]

  • 7. Serum bone specific alkaline phosphatase and urinary deoxypyridinoline in postmenopausal osteoporosis.
    Nawawi HM, Yazid TN, Ismail NM, Mohamad AR, Nirwana SI, Khalid BA.
    Malays J Pathol; 2001 Dec 20; 23(2):79-88. PubMed ID: 12166596
    [Abstract] [Full Text] [Related]

  • 8. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
    Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliffe A, Lindsay R.
    J Bone Miner Res; 1993 Jul 20; 8(7):881-9. PubMed ID: 8352070
    [Abstract] [Full Text] [Related]

  • 9. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis.
    Lumachi F, Ermani M, Camozzi V, Tombolan V, Luisetto G.
    Ann N Y Acad Sci; 2009 Sep 20; 1173 Suppl 1():E60-3. PubMed ID: 19751416
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression.
    Petronijević M, Petronijević N, Ivković M, Stefanović D, Radonjić N, Glisić B, Ristić G, Damjanović A, Paunović V.
    Bone; 2008 Mar 20; 42(3):582-90. PubMed ID: 18226593
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Assessment of bone metabolism and mineral density in chronic viral hepatitis.
    Yenice N, Gümrah M, Mehtap O, Kozan A, Türkmen S.
    Turk J Gastroenterol; 2006 Dec 20; 17(4):260-6. PubMed ID: 17205403
    [Abstract] [Full Text] [Related]

  • 15. [Effects of Migu tablet on bone mineral density, serum matrix metalloproteinase-2 level and bone metabolic markers in postmenopausal osteoporosis].
    Dai Y, Shen L.
    Zhongguo Zhong Yao Za Zhi; 2007 Nov 20; 32(22):2409-12. PubMed ID: 18257271
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E.
    J Obstet Gynaecol Res; 2009 Feb 20; 35(1):152-9. PubMed ID: 19215563
    [Abstract] [Full Text] [Related]

  • 18. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women.
    Zofkova I, Hill M.
    Endocr Regul; 2008 Sep 20; 42(4):121-7. PubMed ID: 18999899
    [Abstract] [Full Text] [Related]

  • 19. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.
    Bai XL, Liang TB, Wu LH, Li DL, Geng L, Wang WL, Shen Y, Zhang M, Zheng SS.
    Transplant Proc; 2007 Dec 20; 39(10):3182-5. PubMed ID: 18089348
    [Abstract] [Full Text] [Related]

  • 20. [Effect of physical activity on bone turnover in young boys].
    Kalaï E, Bahlous A, Nbigh A, Sahli H, Sellami S, Abdelmoula J.
    Ann Biol Clin (Paris); 2007 Dec 20; 65(5):519-24. PubMed ID: 17913670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.